Cytokine profile depending on titers of anti-SARS-CoV-2 IgG in the blood plasma of healthy volunteers

被引:0
|
作者
Krenytska, Daryna [1 ]
Rachkovska, Antonina [1 ]
Karbovskyy, Vitalii [2 ]
Raksha, Nataliia [1 ]
Vovk, Tetiana [1 ]
Savchuk, Olexii [1 ]
Ostapchenko, Liudmyla [1 ]
Halenova, Tetiana [1 ]
机构
[1] Taras Shevchenko Natl Univ Kyiv, Educ & Sci Ctr, Inst Biol & Med, 64-13 Volodymyrska Str, UA-01601 Kiev, Ukraine
[2] LLC BIOPHARMA PLASMA, Kiev, Ukraine
关键词
IgG; cytokine profile; donors;
D O I
10.4081/jbr.2023.11256
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Post-COVID-19 conditions are the subject of extensive scientific study. It is known that system disorders may persist in people who recover from COVID-19 for 3 to 12 months (in most cases). The first line of systemic disorders is dysfunction of the immune system, especially the cytokine profile. The mechanism of the launch of immune complications is currently unknown. We hypothesized that anti-SARS-CoV-2 IgG might trigger the development of post-COVID-19 complications. Our research aimed to study the cytokine profile (including IL-1 beta, IL-4, IL-6, IL-8, IL-10, IL-12 beta, TNF-alpha, IFN-gamma) and the transcription factor NF-kB in the blood plasma of donor groups depending on various titers of anti-SARS-CoV-2 IgG. We determined the qualitative values of the cytokine parameters using ELISA (Enzyme Linked Immunosorbent Assay). We estimated the changes in the cytokine profiles in all donor groups. Differences between donor groups were established for each research parameter. We detected changes in NF-kappa B levels as a key transcription factor for the expression of inflammatory cytokines. The highest level was found in the donor group with a titer of anti-SARS-CoV-2 IgG 75 +/- 5 Index (S/C). We detected some differences between donor groups in the levels of pro-inflammatory cytokines compared to a reference point. IL-1 beta, IL-6, IL-8, INF-gamma, and TNF-alpha levels changed in most donor groups with titers of anti-SARS-CoV-2 IgG >= 10 +/- 3 Index (S/C). In addition, we showed that the decrease in anti-inflammatory cytokine IL-4 in donor groups ranged from the titer of anti-SARS-CoV-2 IgG 55 +/- 5 Index (S/C) to 85 +/- 5 Index (S/C), but these changes for the anti-inflammatory cytokine IL-10 were not detected. We found that the cytokine profile may be affected during post-COVID-19 conditions. The cytokine profiles of the donor groups changed depending on the titers of anti-SARS-CoV-2 IgG. The obtained results testify to the fact that the antibody subpopulation may be a key reason for immune dysfunction, influencing the development of other pathological processes.
引用
收藏
页数:8
相关论文
共 50 条
  • [31] Anti-SARS-CoV-2 IgG and IgM detection with a GMR based LFIA system
    Bayin, Qiaoge
    Huang, Lei
    Ren, Chunhui
    Fu, Yusheng
    Ma, Xing
    Guo, Jinhong
    TALANTA, 2021, 227 (227)
  • [32] Picture of the Favourable Immune Profile Induced by Anti-SARS-CoV-2 Vaccination
    Lanuti, Paola
    Rossi, Claudia
    Cicalini, Ilaria
    Pierdomenico, Laura
    Damiani, Verena
    Semeraro, Daniela
    Verrocchio, Sara
    Del Boccio, Piero
    Evangelista, Adelia
    Sarra, Annalina
    Zucchelli, Mirco
    Bologna, Giuseppina
    Simeone, Pasquale
    Catitti, Giulia
    Di Marco, Federica
    Stefanetti, Simone
    Vespa, Simone
    Sinjari, Bruna
    Bucci, Ines
    De Laurenzi, Vincenzo
    Di Battista, Tonio
    Stuppia, Liborio
    Pieragostino, Damiana
    BIOMEDICINES, 2021, 9 (08)
  • [33] Aberrant glycosylation of anti-SARS-CoV-2 spike IgG is a prothrombotic stimulus for platelets
    Bye, Alexander P.
    Hoepel, Willianne
    Mitchell, Joanne L.
    Jegouic, Sophie
    Loureiro, Silvia
    Sage, Tanya
    Vidarsson, Gestur
    Nouta, Jan
    Wuhrer, Manfred
    de Taeye, Steven
    van Gils, Marit
    Kriek, Neline
    Cooper, Nichola
    Jones, Ian
    den Dunnen, Jeroen
    Gibbins, Jonathan M.
    BLOOD, 2021, 138 (16) : 1481 - 1489
  • [34] Clinical Performance of the VITROS® Immunodiagnostic Products Anti-Sars-Cov-2 IgG Assay
    Contestable, Paul
    Noeson, Charles
    Hosimer, Philip
    Novick, Bethany
    Cark, Sierra
    Colvin, Michael
    TRANSFUSION, 2020, 60 : 89A - 89A
  • [35] Demographic and occupational determinants of anti-SARS-CoV-2 IgG seropositivity in hospital staff
    Martin, Christopher A.
    Patel, Prashanth
    Goss, Charles
    Jenkins, David R.
    Price, Arthur
    Barton, Linda
    Gupta, Pankaj
    Zaccardi, Francesco
    Jerina, Helen
    Duraisingham, Sai
    Brunskill, Nigel J.
    Khunti, Kamlesh
    Pareek, Manish
    JOURNAL OF PUBLIC HEALTH, 2022, 44 (02) : 234 - 245
  • [36] Characteristics of Products of Fibrinogen Origin in the Presence of Anti-SARS-CoV-2 IgG in the Bloodstream
    RACHKOVSKA, A. N. T. O. N. I. N. A.
    KRENYTSKA, D. A. R. Y. N. A.
    KARBOVSKYY, V. I. T. A. L., II
    HALENOVA, T. E. T. I. A. N. A.
    RAKSHA, N. A. T. A. L. I. I. A.
    VOVK, T. E. T. I. A. N. A.
    SAVCHUK, O. L. E. X., II
    LIUBENKO, D. M. Y. T. R. O.
    FALALYEYEVA, T. E. T. Y. A. N. A.
    OSTAPCHENKO, L. I. U. D. M. Y. L. A.
    ABENAVOLI, L. U. D. O. V. I. C. O.
    REVIEWS ON RECENT CLINICAL TRIALS, 2023, 18 (01) : 69 - 75
  • [37] Kinetics of Anti-SARS-CoV-2 IgG among healthcare workers in a General Hospital
    Leli, Christian
    Callegari, Tiziana
    Cassinari, Maurizio
    Rocchetti, Andrea
    NEW MICROBIOLOGICA, 2021, 44 (02): : 84 - 88
  • [38] Lack of cross-reactivity between anti-A IgG isoagglutinins and anti-SARS-CoV-2 IgG antibodies
    Franchini, Massimo
    Moi, Paola
    Cortellazzi, Marzia
    Danese, Nadia
    Caruso, Stefania
    Pasolini, Paola
    Ferrazzo, Sabina
    Piccinini, Stefania
    Dall'Oglio, Anna
    Zovetti, Paola
    Negri, Nadia
    Braga, Donatella
    Pasquali, Cristina
    Zuliani, Elisa
    Glingani, Claudia
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2021, 59 (07) : E279 - E281
  • [39] Detection of Anti-SARS-CoV-2 Antibodies
    Jahrsdoerfer, Bernd
    Schrezenmeier, Hubert
    TRANSFUSIONSMEDIZIN, 2021, 11 (03) : 182 - 187
  • [40] Seroprevalence of anti-SARS-CoV-2 antibodies and risk factors among healthy blood donors in Luanda, Angola
    Cruz S. Sebastião
    Manuela Galangue
    Celestina Gaston
    Rui Van-Dunen
    Joltim Quivinja
    Emiliana Lunbungululo
    Domingos Alfredo
    Alberto Sozinho
    Alice Teixeira
    Eunice Manico
    Deodete Machado
    António Mateus
    Zinga David
    Joana Paixão
    Zoraima Neto
    Jocelyne Neto de Vasconcelos
    Joana Morais
    BMC Infectious Diseases, 21